[Other] Moving forward in IPF: lessons learned from clinical trials |
Reward30points
Best Answer
2024-6-17
|
| |
40
The Best Exercise Modality and Dose to Reduce Glycosylated Hemoglobin in Patients with Type 2 Diabetes: A Systematic Review with Pairwise, Network, and Dose–Response Meta-Analyses
20
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Primary Results From AMEERA-5
20
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I.
20
Quantifying Substrate Protein Secretion via the Type III Secretion System of the Bacterial Flagellum
20
[Single chapter]Talking About Regulation
